Management of COVID-19 in 55 hemodialysis patients: Experience from Eastern Turkey

Creative Commons License

Sevinç C., Timur O., Utlu M., Çankaya E.

ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, cilt.12, sa.4, ss.438-442, 2021 (ESCI) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 12 Sayı: 4
  • Basım Tarihi: 2021
  • Doi Numarası: 10.4328/acam.20508
  • Dergi Adı: ANNALS OF CLINICAL AND ANALYTICAL MEDICINE
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI)
  • Sayfa Sayıları: ss.438-442
  • Atatürk Üniversitesi Adresli: Evet

Özet

Aim: The novel coronavirus causes acute severe respiratory syndrome (SARS COV 2), and the disease is named COVID-19. The virus spreads easily, and COVID-19 may be asymptomatic or cause severe pneumonia and ARDS. Hemodialysis patients are affected by COVID-19 because of the immunosuppression caused by uremia, comorbid diseases and the risk of cross-contamination during dialysis. In this study, we aimed to examine the clinical features and outcomes of 55 hemodialysis patients diagnosed with COVID-19.